Answers are grounded in this paper and cite their sources.
Summary Neoplasms of the lymphoid tissues represent a large, heterogeneous group of diseases that vary in clinical severity and response to treatment. The incidence of lymphoma in older patients is growing, yet guidelines on specifically how these patients should be treated are lacking. Moreover, older people are excluded from most of the clinical trials and management decisions are usually based on data obtained in younger patients. This review might consider the optimal strategy for lymphoma diagnosis and treatment in older patients.
No takes yet. Share an insight, caveat, or question.
Benavente et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: